Current position:Home >Product >
L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-y l)carbonyl)-4-hydroxy-, trans-
L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-y l)carbonyl)-4-hydroxy-, trans-(64398-32-9)
- Name: L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-y l)carbonyl)-4-hydroxy-, trans-
- Synonyms:L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-y l)carbonyl)-4-hydroxy-, trans-
- Molecular Formula:C16H16 Cl N O6
- Molecular Weight:353.75
- CAS Registry Number:64398-32-9
- EINECS:
- Melting Point:
- Water Solubility:
![Purchasing Requirement](/images/Purchasing-Requirement.gif)
Other Product
- 21599-20-2/2,3,4,4a,5,6-Hexahydro-α-methyl-1H-pyrazino[1,2-a]quinoline-3-(1-propanol)
- 56539-66-3/3-Methyl-3-methoxybutanol
- 5450-74-8/1,4-dimethyl-1,4-diazoniabicyclo[2.2.2]octane
- 204315-20-8/BAS 518-4
- 59866-17-0/1,2,3-trimethyl-5-nitro-1H-imidazol-3-ium
- 69570-85-0/4-Pyridinemethanol,3,3'-[(6-methyl-2,4-pyrimidinediyl)bis(4,1-piperazinediylmethylene)]bis[5-hydroxy-6-methyl-(9CI)
- 68239-90-7/Formaldehyde, polymer with 1,2-propanediol and 1,3,5-triazine-2,4,6-triamine
- 138935-66-7/5H-Oxireno[8,8a]naphtho[1,2-b]furan-7(6H)- one,3,3a,4,5a,8a,9a-hexahydro-3-hydroxy- 3a,9a-dimethyl-6-methylene-,(3S,3aS,5aS,- 8aS,8bR,9aR)-
- 173294-77-4/1H-Benz[e]indene-6-propanoic acid,4-[(6-deoxy-â-D-glucopyranosyl)oxy]- dodecahydro-6,9a,9b-trimethyl-7-(1-methylethenyl)- 3-[(2S,5R)-tetrahydro-5-(1- hydroxy-1-methylethyl)-2-methyl-2- furanyl]-,(3S,3aR,4R,5aR,6S,7S,9aR,9bR)-
- 18105-31-2/BIS(TRIMETHYLSILYL) ADIPATE
- 80102-04-1/ACETYL-BETA-ENDORPHIN (HUMAN)
- 10539-19-2/moxaverine
- 68259-36-9/N-phenyl-1,1,3,3-tetramethylbutylnaphthalen-1-amine
- 18720-62-2/2-METHYL-3-HEPTANOL
- 6876-44-4/Silyl trifluoroacetate
- 95754-66-8/2'-O-(N-(2-aminoethyl)carbamoylethyl)phosphono-NAD
- 13994-11-1/3-ethyl-2-(1-methylpiperidin-2-yl)-1H-indole
- 83550-95-2/{1-[(1-nitroacridin-9-yl)amino]ethyl}phosphonic acid hydrochloride (1:1)
- 19977-14-1/1-Piperazinecarboxylic acid, 4-(2-benzoyloxy-3-(1,3-dimethyl-7-xanthin yl)propyl)-, ethylester
- 64398-32-9/L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-y l)carbonyl)-4-hydroxy-, trans-
- 31839-62-0/2,2-dimethyl-4,5-diphenyl-2H-imidazole
- 100198-13-8/2-Butenoic acid,2-methyl-,(3S,3aS,5aR,5bR,6S,8R,8aR,10aR,10bR,11S,11aS,11bR,12aS)-8-(acetyloxy)-3-(3-furanyl)tetradecahydro-11-hydroxy-3a,5b,8a,11a-tetramethyl-1-oxo-3H-furo[4',3',2':8,9]phenanthro[2,1-c]oxireno[d]pyran-6-ylester, (2E)- (9CI)
- 117052-25-2/2-hydroxyethanesulfonic acid - 5-methyl-6-{[(3,4,5-trimethoxyphenyl)amino]methyl}quinazoline-2,4-diamine (1:1)
- 63441-59-8/2,3,5,6-Tetramethyl-1,4-dinitrosopiperazine
- 71050-60-7/1,3-Benzenedicarboxylic acid, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, 2,2-dimethyl-1,3-propanediol, 2-(hydroxymethyl)-2-methyl-1,3-propanediol and nonanedioic acid
- 106063-42-7/4-(acridin-9-ylamino)-3-methoxyphenol
- 63927-84-4/5-(1H-imidazol-2-ylmethyl)-2H-tetrazole
- 73905-69-8/ACTH, 2-nitro-5-azidophenylsulfenyl-
- 24813-09-0/2-({2-[bis(2-chloroethyl)amino]benzoyl}oxy)-N,N-diethylethanaminium chloride
- 2801-54-9/3,5-dimethylnorleucine